2001
DOI: 10.1056/nejm200104193441607
|View full text |Cite
|
Sign up to set email alerts
|

Genetic Susceptibility to Venous Thrombosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

11
460
6
51

Year Published

2002
2002
2014
2014

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 733 publications
(533 citation statements)
references
References 100 publications
11
460
6
51
Order By: Relevance
“…19 In our study, in which patients were re-examined 1 to 18 years after the first DVT episode (median five years), we observed a high rate of DVT recurrence: 36% and 32% in the TG and CG respectively. Four thrombophilic patients had rethrombosis while on increasing the risk of thrombotic events by five to ten times in heterozygotic carriers and more than ten times in homozygotic patients, 6,11 especially in association with other risk factors such as advanced age (over 65) or oral contraceptive use, 7,9,15,29 which was the second most common risk factor in our patient sample.…”
Section: Discussionmentioning
confidence: 66%
See 1 more Smart Citation
“…19 In our study, in which patients were re-examined 1 to 18 years after the first DVT episode (median five years), we observed a high rate of DVT recurrence: 36% and 32% in the TG and CG respectively. Four thrombophilic patients had rethrombosis while on increasing the risk of thrombotic events by five to ten times in heterozygotic carriers and more than ten times in homozygotic patients, 6,11 especially in association with other risk factors such as advanced age (over 65) or oral contraceptive use, 7,9,15,29 which was the second most common risk factor in our patient sample.…”
Section: Discussionmentioning
confidence: 66%
“…The incidence of spontaneous thromboembolism in patients with these deficiencies is estimated at 0.4% per year, while the rate for secondary thromboembolisms associated with other triggering risk factors increases to between 8.1% and 10%. 6,10,11 The most common of these is the factor V R306Q mutation (FV Leiden) which causes resistance to the action of PC, appearing in 1 to 15% of the general population and in 10 to 50% of patients with VTE. 12,13 The G20210A polymorphism of the prothrombin gene is associated with increased plasma prothrombin levels and is present in 1 to 3% of individuals in the general population and 6 to 18% of patients with VTE.…”
Section: Introductionmentioning
confidence: 99%
“…Most of these genetic variations are risk factors for venous thrombosis and have minor role in arterial thrombosis: protein C, protein S and antithrombin deficiencies, activated protein C (APC) resistance mainly due to factor V Leiden mutation, and factor II G20210A mutation [16]. More recently, other inherited defects have been suspected to play a role in arterial thrombosis: platelet receptor polymorphisms (C807T allele of GPIa/IIa, HPLA1 and HPLA2 of GPIIIa, GPIb alpha), hyperhomocysteinemia due to mutation C677T of 5, 10-methylenetetrahydrofolate reductase (MTHFR) gene, and cystathionine β synthetase deficiency, as well as high levels of factors VII and VIII.…”
mentioning
confidence: 99%
“…Other risk factors are placement of a central venous catheter, infection, trauma, medications (Lasparaginase, OCP), chronic medical illness (nephrotic syndrome, malignancy), pregnancy, immobilisation and hereditary factors [4]. Among hereditary factors, factor V Leiden mutation found to be the commonest cause [6]. Molecular basis of protein 'C' deficiency has been studied extensively.…”
Section: Discussionmentioning
confidence: 99%